Lanzone, Antonio
 Distribuzione geografica
Continente #
EU - Europa 9.328
NA - Nord America 8.784
AS - Asia 3.266
SA - Sud America 572
AF - Africa 80
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.065
Nazione #
US - Stati Uniti d'America 8.693
DE - Germania 2.809
SE - Svezia 1.462
PL - Polonia 1.344
SG - Singapore 1.244
CN - Cina 1.116
IT - Italia 976
UA - Ucraina 634
BR - Brasile 515
FR - Francia 508
IE - Irlanda 414
GB - Regno Unito 384
ID - Indonesia 255
FI - Finlandia 254
IN - India 183
RU - Federazione Russa 166
TR - Turchia 119
BE - Belgio 89
CA - Canada 64
AT - Austria 56
HK - Hong Kong 56
IR - Iran 53
KR - Corea 50
NL - Olanda 50
CI - Costa d'Avorio 47
CZ - Repubblica Ceca 37
JP - Giappone 36
AU - Australia 21
AR - Argentina 20
ES - Italia 19
CH - Svizzera 18
LT - Lituania 17
VN - Vietnam 15
MX - Messico 14
NO - Norvegia 14
PK - Pakistan 14
RO - Romania 14
PT - Portogallo 12
IL - Israele 11
LV - Lettonia 11
BD - Bangladesh 10
IQ - Iraq 10
MA - Marocco 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CO - Colombia 9
PE - Perù 9
ZA - Sudafrica 9
CL - Cile 8
NZ - Nuova Zelanda 8
EG - Egitto 7
PH - Filippine 7
KZ - Kazakistan 6
HU - Ungheria 5
JO - Giordania 5
LA - Repubblica Popolare Democratica del Laos 5
LK - Sri Lanka 5
LU - Lussemburgo 5
PA - Panama 5
RS - Serbia 5
AL - Albania 4
BG - Bulgaria 4
EC - Ecuador 4
MY - Malesia 4
TH - Thailandia 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EU - Europa 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
MD - Moldavia 3
SA - Arabia Saudita 3
TW - Taiwan 3
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
MN - Mongolia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
MC - Monaco 1
Totale 22.056
Città #
Chandler 1.949
Warsaw 1.310
Singapore 787
Ashburn 724
Dublin 409
Jacksonville 380
San Mateo 362
Fairfield 283
New York 281
Wilmington 256
Jakarta 252
Ann Arbor 194
Boston 185
Milan 183
Woodbridge 182
Nanjing 176
Nürnberg 174
Marseille 171
Dearborn 168
Houston 165
Seattle 162
Princeton 144
The Dalles 142
Los Angeles 141
Rome 135
Lancaster 118
Beijing 117
Cattolica 115
Bremen 113
Cambridge 113
Helsinki 109
Moscow 102
Munich 92
Izmir 87
Brussels 85
Redwood City 80
Frankfurt am Main 77
Lawrence 77
Hefei 74
Nanchang 68
Düsseldorf 60
Mountain View 59
University Park 56
Shenyang 50
Abidjan 47
Augusta 47
Chicago 47
Leawood 46
Zhengzhou 45
Hebei 44
Seoul 44
London 43
Nuremberg 41
São Paulo 41
Hong Kong 40
Norwalk 39
Shanghai 38
Fremont 37
Redmond 37
Vienna 37
Boardman 35
Pune 35
Kraków 27
Toronto 27
Hangzhou 26
Lauterbourg 26
Oggiono 26
Jiaxing 25
Paris 25
Brno 24
Guangzhou 24
Tianjin 24
Changsha 23
Kish 23
Portsmouth 22
Busto Arsizio 20
Washington 20
Kunming 19
Rio de Janeiro 19
San Francisco 19
Andover 18
Phoenix 18
Tokyo 18
Falkenstein 17
Naples 17
Jinan 16
Ottawa 16
Santa Clara 16
Zurich 14
Belo Horizonte 13
Falls Church 13
San Giovanni Bianco 13
Simi Valley 13
San Diego 12
Amsterdam 11
Atlanta 11
Guarulhos 11
Montreal 11
North Bergen 11
Riga 11
Totale 12.409
Nome #
Effect of human chorionic gonadotropin administration on pituitary and luteal response to gonadotropin-releasing hormone 357
In vitro human growth hormone increases human chorionic gonadotropin and progesterone secretion by human placenta at term: evidence of a modulatory role by opioids 299
Indomethacin in vivo inhibits the enhancement of the progesterone secretion in response to gonadotrophin-releasing hormone by human corpus luteum 276
Effect of activin-A on progesterone synthesis in human luteal cells 273
Effect of activin-A on progesterone synthesis in human luteal cells 273
Insulin secretion in patients with gestational diabetes: relationship with pregnancy outcome 268
Human growth hormone enhances progesterone production by human luteal cells in vitro. II. Evidence of a distinct effect on two luteal cell types 264
Insulin plasma levels in pregnant patients with impaired glucose tolerance: relationship with pregnancy outcome 264
Insulin-like growth factor (IGF)-I and IGF-II stimulate progesterone production by human luteal cells: role of IGF-I as mediator of growth hormone action 262
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease 247
Endometriosis and human infertility: a new investigation into the role of eutopic endometrium 231
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. 220
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome 198
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 172
Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. 167
Assessment of insulin resistance in lean women with polycystic ovary syndrome. 156
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT 156
Excretion of SARS-CoV-2 in human breast milk 153
L'applicazione del Nuovo Ordinamento del CLM in Medicina e Chirurgia. Le ragioni di un percorso e di una proposta innovativa di Piano di studi nella Facoltà di Medicina e Chirurgia dell'Università Cattolica di Roma 148
The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status 143
CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes 143
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 142
Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics 142
17β-estradiol protects cerebellar granule cells against β-amyloid-induced toxicity via the apoptotic mitochondrial pathway 139
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 133
Is there any role for the Hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment? 132
Prokineticin 1 mRNA expression in the endometrium of healthy women and in the eutopic endometrium of women with endometriosis. 131
Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact 129
Prenatal diagnosis, natural history, postnatal treatment and outcome of 222 cases of spina bifida: experience of a tertiary center 129
Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women. 127
Adult onset Still's disease and pregnancy 125
Look at the lung: can chest ultrasonography be useful in pregnancy? 124
Carbohydrate metabolism in gestational diabetes: effect of chronic hypertension 123
Prenatal diagnosis, natural history, postnatal treatment and outcome of 222 cases of spina bifida: experience of a tertiary center 122
Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women 121
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 121
Is gestational hypertension beneficial in twin pregnancies? 120
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 119
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 119
The use of different size-hysteroscope in office hysteroscopy: our experience 118
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 118
Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation. 115
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples 115
Ovarian Volume And Gluco-Insulinaemic Markers In The Diagnosis Of Pcos During Adolescence 112
Look at the lung: can chest ultrasonography be useful in pregnancy? 112
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 111
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. 109
Metformin versus myoinositol: which is better in obese PCOS patients? A randomized controlled crossover study 108
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 107
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 107
Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. 105
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 105
L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism 104
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 104
Delivery Management in Maternal Varicella Peripartum Infection with Vulvar Lesions: A Case Report 104
How Metformin Acts in PCOS Pregnant Women: Insights in insulin secretion and peripheral action at each trimester of gestation. 103
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 103
Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study 103
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 102
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study 102
The transition from intra to extra-uterine life in late preterm infant: a single-center study 102
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 101
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 101
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 100
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 100
Autoimmunity in obstetrics and autoimmune diseases in pregnancy 100
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis 99
Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women 99
Fasting and post-methionine homocysteine levels in Alzheimers disease and vascular dementia 99
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial 99
The transition from intra to extra-uterine life in late preterm infant: a single-center study 99
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 98
Metformin versus myoinositol: which is better in obese PCOS patients? A randomized controlled crossover study. 98
A multi-approach management intervention can lower C-section rate trends: The experience of a Third Level Referral Center de Belvis A.G., Neri C., Angioletti C., Carducci B., Ferrazzani S., Lanzone A., Caruso A. 98
Prenatal valacyclovir treatment of fetal citomegalovirus infection: A case series 96
Insulin Secretory Patterns and Uteroplacental Doppler Flow Velocimetry in Pregnancies Complicated by Carbohydrate Intolerance: Is There any Relationship? 95
Effects of oral glucose administration on plasma growth hormone levels in women with polycystic ovary syndrome 94
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 94
Look at the lung: can chest ultrasonography be useful in pregnancy? 94
Role of Human Leukocyte Antigens at the Feto-Maternal Interface in Normal and Pathological Pregnancy: An Update. 94
Twin pregnancy using recombinant gonadotrophins in a woman with hypogonadotrophin hypogonadism. 93
Using a 16-French resectoscope as an alternative device in the treatment of uterine lesions: a randomized controlled trial 93
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation 93
Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? 93
Knowledge and beliefs about vaccination in pregnant women before and during the COVID-19 pandemic 91
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 91
Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome 91
Risk Factors for Coarctation of the Aorta on Prenatal Ultrasound: A Systematic Review and Meta-Analysis 91
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 91
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy. 91
Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy. 90
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 90
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 89
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 88
Epidermal growth factor levels in human breast cyst fluid 88
Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective 86
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 86
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 86
Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? 86
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action 86
Totale 12.988
Categoria #
all - tutte 98.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020501 0 0 0 0 0 0 0 0 0 0 310 191
2020/20211.816 95 185 58 184 243 119 232 33 242 78 289 58
2021/20222.097 161 138 32 168 81 83 49 383 79 117 342 464
2022/20235.089 649 684 374 814 280 665 281 409 589 93 185 66
2023/20242.477 116 628 70 122 97 440 211 89 43 109 215 337
2024/20253.970 112 147 367 181 521 152 174 266 719 501 830 0
Totale 22.422